Kraig Biocraft Laboratories, Inc.
KBLB
$0.09
$0.0055.88%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -851.70K | -433.20K | -1.61M | -507.90K | -1.32M |
| Total Depreciation and Amortization | 19.80K | 59.30K | 6.70K | 6.70K | 27.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 54.10K | -113.30K | 886.00K | -90.60K | 640.20K |
| Change in Net Operating Assets | 265.30K | 160.90K | 202.70K | 102.20K | 328.90K |
| Cash from Operations | -512.50K | -326.30K | -510.80K | -489.50K | -327.70K |
| Capital Expenditure | -4.20K | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -4.20K | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -5.20K | -15.00K | -15.00K | -15.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | -5.20K | -15.00K | -15.00K | -15.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -516.80K | -331.50K | -525.80K | -504.50K | -342.70K |